DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
TH-302 is an investigational drug.
There have been 24 clinical trials for TH-302. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2011.
The most common disease conditions in clinical trials are Pancreatic Neoplasms, Sarcoma, and Adenocarcinoma. The leading clinical trial sponsors are Threshold Pharmaceuticals, Merck KGaA, and EMD Serono.
There are twenty-seven US patents protecting this investigational drug and four hundred and seventy-five international patents.
Recent Clinical Trials for TH-302
|Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.||Threshold Pharmaceuticals||Phase 1|
|Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.||Zuyderland Medical Centre||Phase 1|
|Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.||Maastricht Radiation Oncology||Phase 1|
Top disease conditions for TH-302
Top clinical trial sponsors for TH-302
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|TH-302||Get Started for $10||Predictive biomarker for hypoxia-activated prodrug therapy||Molecular Templates, Inc. (Austin, TX)||Get Started for $10|
|TH-302||Get Started for $10||TH-302 solid forms and methods related thereto||Molecular Templates, Inc. (Austin, TX)||Get Started for $10|
|TH-302||Get Started for $10||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||Get Started for $10|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|TH-302||World Intellectual Property Organization (WIPO)||WO2015069489||2033-11-06||Get Started for $10|
|TH-302||World Intellectual Property Organization (WIPO)||WO2016011195||2034-07-17||Get Started for $10|
|TH-302||Australia||AU2017261372||2036-05-05||Get Started for $10|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|